Dr. Matthew Taylor, MD
Claim this profileProvidence Portland Medical Center
Area of expertise
Non-Small Cell Lung Cancer
Matthew Taylor, MD has run 6 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Squamous Cell Carcinoma
Matthew Taylor, MD has run 6 trials for Squamous Cell Carcinoma. Some of their research focus areas include:
Affiliated Hospitals
Providence Portland Medical Center
Providence Cancer Institute
Clinical Trials Matthew Taylor, MD is currently running
EP0031
for Cancer
The aim of this study is to assess the safety, side effects and effectiveness of EP0031 (Lunbotinib) in patients with advanced RET-altered non-small cell lung cancer (NSCLC) in monotherapy and in combination with standard of care (SOC) chemotherapy.
Recruiting
1 award
Phase 1 & 2
Gene Therapy
for Right Ventricular Cardiomyopathy
This first-in-human study is designed to evaluate the safety, and preliminary efficacy (PD) of TN-401 gene therapy in adult patients with symptomatic PKP2 mutation-associated ARVC.
Recruiting
1 award
Phase 1
6 criteria
More about Matthew Taylor, MD
Clinical Trial Related
5 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Matthew Taylor, MD has experience with
- Pembrolizumab
- Nivolumab
- Cabozantinib
- Cemiplimab
- Placebo
- Sham Device
Breakdown of trials Matthew Taylor, MD has run
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Melanoma
Head and Neck Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew Taylor, MD specialize in?
Matthew Taylor, MD focuses on Non-Small Cell Lung Cancer and Squamous Cell Carcinoma. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are PD-L1 positive.
Is Matthew Taylor, MD currently recruiting for clinical trials?
Yes, Matthew Taylor, MD is currently recruiting for 5 clinical trials in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Matthew Taylor, MD has studied deeply?
Yes, Matthew Taylor, MD has studied treatments such as Pembrolizumab, Nivolumab, Cabozantinib.
What is the best way to schedule an appointment with Matthew Taylor, MD?
Apply for one of the trials that Matthew Taylor, MD is conducting.
What is the office address of Matthew Taylor, MD?
The office of Matthew Taylor, MD is located at: Providence Portland Medical Center, Portland, Oregon 97213 United States. This is the address for their practice at the Providence Portland Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.